Projects Showing 1 - 18 out of 19 results Filter by Program - Any -Asia and Pacific Health ProgramBiosecurity ProgramBiostatistics and Databases ProgramGlobal Health ProgramHIV Epidemiology and Prevention ProgramImmunovirology and Pathogenesis ProgramInfection Analytics ProgramSexual Health ProgramSurveillance and Evaluation Research ProgramTherapeutic and Vaccine Research ProgramViral Hepatitis Clinical Research ProgramViral Hepatitis Epidemiology and Prevention ProgramViral Immunology Systems ProgramYandamanjang First Nations Health Research Program Keywords Focus areas - Any -Aboriginal and Torres Strait Islander healthCOVID-19 and emerging infectionsGlobal healthHIVHPVSexual healthViral hepatitis Research strengths - Any -Biostatistics, modelling and analysisCapacity buildingClinical trials and cohortsEpidemiology and surveillanceHealth economics and health systemsImmunovirologyNew diagnostic approachesPublic health interventionsSocial and behavioural sciences Status - Any -CurrentCompleted View more Sort by Earliest firstLatest firstTitle A - ZTitle Z - A STRIVE Trial 1: Shionogi Protease Inhibitor (S-217622) STRIVE Trial 2: Immune Modulation Strategy Trial (IM Strategy) PHASE The Pharmaco-AI Infectious Disease Surveillance (PHASE) project OPTIMAR Optimising metabolic management on integrase based ART The CIRCUIT Study Comparing Immunisation-Boosting Regimens for COVID-19 Upon Initiation of immunosuppressive Therapies Study REal World Assessment of people living with Chronic Hepatitis B in Australia (REACH-B) HBV POCT Evaluation of a novel hepatitis B DNA test from capillary blood at the point-of-care as a tool to enhance clinical management STRIVE Strategies and Treatments for Respiratory Infections and Viral Emergencies D²EFT: Dolutegravir and Darunavir Evaluation in adults Failing Therapy Age-Related Clonal Haematopoiesis in an HIV Evaluation Cohort (ARCHIVE) Inpatient Treatment with Anti-Coronavirus Immunoglobulin (ITAC) ADAPT Study TICO Therapeutics for Hospitalized Patients with COVID-19 Project Strategic Timing of AntiRetroviral Treatment (START) International SARS-CoV-2 Infection Observational Study (ICOS) COHIVE: Coronavirus Outcomes in HIV Evaluation in Resource Limited Settings Coronavirus Outcomes Registries in Immunocompromised Individuals Australia (CORIA) FLU-IVIG Pagination Current page 1 Page 2 Next page > Last page >>
The CIRCUIT Study Comparing Immunisation-Boosting Regimens for COVID-19 Upon Initiation of immunosuppressive Therapies Study
HBV POCT Evaluation of a novel hepatitis B DNA test from capillary blood at the point-of-care as a tool to enhance clinical management
